Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Survival rates with two approaches were similar, but one came with more complications ...

Learn about prostate cancer, its diagnosis, treatment options, and the latest study findings. Understand which types need ...

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

But an association with improved overall survival failed to reach statistical significance ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

A recent prospective study highlights the substantial burden of late RT-related genitourinary complications among men with ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...